Table 3 Patients’level of knowledge regarding DMARDs according to general practitioners
n (%) | |||||
|---|---|---|---|---|---|
Very insufficient | Insufficient | No opinion | Appropriate | Excellent | |
Mechanism of action | 67 (27.1%) | 104 (42.1%) | 61 (24.7%) | 13 (5.3%) | 2 (0.8%) |
Potential adverse effects and associated behaviours | 15 (6.1%) | 121 (49.0%) | 44 (17.8%) | 66 (26.7%) | 1 (0.4%) |
Frequency of administration | 9 (3.6%) | 36 (14.6%) | 35 (14.2%) | 157 (63.6%) | 10 (4.0%) |
Vaccination status | 31 (12.6%) | 128 (51.8%) | 32 (13.0%) | 50 (20.2%) | 6 (2.4%) |
Biosimilars | 72 (29.1%) | 98 (39.7%) | 66 (26.7%) | 10 (4.0%) | 1 (0.4%) |
Self-injection | 25 (10.1%) | 64 (25.9%) | 83 (33.6%) | 72 (29.1%) | 3 (1.2%) |